CareDx Reports Q2 2024 Results and Increases Revenue Guidance

August 1, 2024

DENVER, Colo., Aug 01, 2024 (247marketnews.com)- CareDx, Inc. (Nasdaq: CDNA) reported its second quarter financial results, including total revenue of $92.3 million, a 31% year-over-year increase, a 17% year-over-year increase in testing services volume, and it raised its 2024 annual revenue guidance to $320 to $328 million and adjusted EBITDA to a gain of $9 to $15 million.

CareDx’s President and CEO, John W. Hanna, commented, “We are pleased to announce another strong quarter, marked by growth across all our businesses. The hard work of our team and their dedication to serving transplant patients over the past year have been instrumental in our performance. As we approach the second half of the year, we remain focused on driving growth,” said

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (CDNA)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.